These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1525686)

  • 1. [Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia].
    Kettner M; Miller GH; Inouye S
    Bratisl Lek Listy; 1992 Mar; 93(3):131-5. PubMed ID: 1525686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
    Miller GH; Sabatelli FJ; Naples L; Hare RS; Shaw KJ
    J Chemother; 1995 Jun; 7 Suppl 2():31-44. PubMed ID: 8622109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial resistance to aminoglycoside antibiotics].
    Kettner M; Macicková T
    Bratisl Lek Listy; 1992 Apr; 93(4):175-8. PubMed ID: 1393633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
    Omoto S; Yoshida T; Kurebe M; Inouye S
    Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria.
    Kettner M; Navarová J; Lebek G; Krcméry V
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):372-82. PubMed ID: 6091367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of dactimicin to aminoglycoside-modifying enzymes.
    Gomez-Lus R; Marco MA; Gomez-Lus ML
    Drugs Exp Clin Res; 1987; 13(12):731-5. PubMed ID: 3447876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
    Kettner M; Krćméry V
    Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
    Jones RN
    J Chemother; 1995 Jun; 7 Suppl 2():7-16. PubMed ID: 8622113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
    Inouye S; Hara T; Matsuhashi Y; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside resistance patterns in Turkey.
    Akalin HE; Torun M; Alacam R
    Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
    J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of isepamicin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium.
    Belgian Isepamicin Multicenter Study Group
    Acta Clin Belg; 2001; 56(5):307-15. PubMed ID: 11774843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
    Yeliz TC; Ali HB; Sarah AF; Sreylis N; Kubra HU; Asuman B
    Indian J Med Microbiol; 2021 Jan; 39(1):59-62. PubMed ID: 33610258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzymatic mechanisms of resistance to aminoglycoside antibiotics in gram negative bacilli from Chilean hospitals].
    Del Solar E; García A; Bello H; Domínguez M; González G; Zemelman R
    Rev Med Chil; 1995 Mar; 123(3):293-7. PubMed ID: 8525167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antibacterial activities of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with those of other aminoglycoside antibiotics.
    Matsuhashi Y; Yoshida T; Hara T; Kazuno Y; Inouye S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):589-94. PubMed ID: 3873901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside resistance patterns in clinical isolates of E. coli and Klebsiella sp. from Czechoslovakia and the United States.
    Navarová J; Kettner K; Krcméry V; Folrichová D
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(4):477-86. PubMed ID: 2696761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.